Latest news
The Manufacturers Life Insurance Company Raises Stake in Monte Rosa Therapeutics, Inc. $GLUE - MarketBeatMarketBeat · Sat, 08 Aug 2026 09:13:44 GMTDimensional Fund Advisors LP Acquires 473,005 Shares of Monte Rosa Therapeutics, Inc. $GLUE - MarketBeatMarketBeat · Sat, 08 Aug 2026 07:49:35 GMTMonte Rosa Therapeutics (GLUE) Stock Faces Mounting Loss Pressure - simplywall.stsimplywall.st · Sat, 08 Aug 2026 05:58:42 GMTJPMorgan Chase & Co. Has Lowered Expectations for Monte Rosa Therapeutics (NASDAQ:GLUE) Stock Price - MarketBeatMarketBeat · Fri, 07 Aug 2026 18:44:16 GMTMonte Rosa Therapeutics Is Maintained at Overweight by Wells Fargo - MoomooMoomoo · Fri, 07 Aug 2026 14:31:02 GMTWells Fargo & Company Lowers Monte Rosa Therapeutics (NASDAQ:GLUE) Price Target to $27.00 - MarketBeatMarketBeat · Fri, 07 Aug 2026 13:59:27 GMTLifeSci Capital Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating - MoomooMoomoo · Fri, 07 Aug 2026 11:32:58 GMTMonte Rosa Therapeutics (GLUE) Is Down 30.7% After Deepening Q2 Losses And H1 Earnings Reversal - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 07:10:56 GMT